Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia.
Laterre, Pierre-François[UCL] Opal, Steven M Abraham, Edward LaRosa, Steven P Creasey, Abla A Xie, Fang Poole, Lona Wunderink, Richard G (2009) Critical care (London, England) — Vol. 13, no. 2, p. R36 (2009)
- Journal article
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis: A Randomized Controlled Trial
OPTIMIST Trial Study Group Abraham, Edward Reinhart, Konrad Opal, Steven Demeyer, Ignace Doig, Christopher López Rodriguez, Angel Beale, Richard Svoboda, Petr Laterre, Pierre-François[UCL] Simon, Stuart Light, Bruce Spapen, Herbert Stone, Judy Seibert, Allan Peckelsen, Claus De Deyne, Cathy Postier, Russell Pettilä, Ville Sprung, Charles L. Artigas, Antonio Percell, Sandra R. Shu, Vincent Zwingelstein, Christian Tobias, Jeffrey Poole, Lona Stolzenbach, James C. Creasey, Abla A. (2003) JAMA : the journal of the American Medical Association — Vol. 290, no. 2, p. 238-247 (2003)